Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Blood|July 7, 2017
Role of ADP receptors on platelets in the growth of ovarian cancerMin Soon Cho, Kyunghee Noh, Monika Haemmerle, et al.
Scientific Reports|May 1, 2021
Combined VEGFR and MAPK pathway inhibition in angiosarcomaMichael J Wagner, Yasmin A Lyons, Jean H Siedel, et al.
Molecular Cancer Therapeutics|September 18, 2016
Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian CancerYan Huang, Lenard M Lichtenberger, Morgan Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Differential platelet levels affect response to taxane-based therapy in ovarian cancerJustin Bottsford-Miller, Hyun-Jin Choi, Heather J Dalton, et al.
Molecular Cancer Therapeutics|December 15, 2017
Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine CancerYan Huang, Wei Hu, Jie Huang, et al.
Genes & Development|July 13, 2017
PRKCI promotes immune suppression in ovarian cancerSharmistha Sarkar, Christopher A Bristow, Prasenjit Dey, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer ModelsPinar Kanlikilicer, Bulent Ozpolat, Burcu Aslan, et al.
Journal of the National Cancer Institute|April 5, 2017
Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine MalignanciesRebecca A Previs, Guillermo N Armaiz-Pena, Cristina Ivan, et al.
Oncotarget|December 13, 2017
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapyYasmin A Lyons, Sunila Pradeep, Sherry Y Wu, et al.
JCI Insight|August 18, 2017
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagensArchana S Nagaraja, Robert L Dood, Guillermo Armaiz-Pena, et al.
Pageof 5